Suicidality and Cannabidiol: Opportunities and Challenges.
Curr Neuropharmacol
; 19(6): 733-735, 2021.
Article
en En
| MEDLINE
| ID: mdl-33059579
ABSTRACT
Cannabidiol (CBD) is gaining considerable attention in the research community with promising results in a variety of neuropsychiatric conditions. In particular, there are replicated findings for the therapeutic effects of CBD on psychotic and anxiety symptoms as well as substance use disorders, all of which are highly prevalent in patients who present with suicidality. Meanwhile, there has been a lack of suicide research on cannabidiol. This perspective provides an overview of the available evidence, potential reasons behind the halt in suicide research on cannabidiol, and recommendations for future investigations.
Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Suicidio
/
Cannabidiol
/
Trastornos Relacionados con Sustancias
Tipo de estudio:
Guideline
Límite:
Humans
Idioma:
En
Revista:
Curr Neuropharmacol
Año:
2021
Tipo del documento:
Article
País de afiliación:
Estados Unidos